What is the recommended approach to spontaneous bacterial peritonitis (SBP) in children with nephrotic syndrome (NS)?

Approach to Spontaneous Bacterial Peritonitis in Children with Nephrotic Syndrome

Start empirical IV third-generation cephalosporin (cefotaxime 50 mg/kg/dose every 6-8 hours or ceftriaxone 50-75 mg/kg/day) immediately upon clinical suspicion of peritonitis in any child with nephrotic syndrome presenting with abdominal pain, fever, or signs of infection.

Diagnostic Approach

Perform diagnostic paracentesis when a child with nephrotic syndrome presents with:

• Abdominal pain (present in 98% of cases) 1
• Fever (95% of cases) 1
• Rebound tenderness (85% of cases) 1
• Nausea/vomiting (71% of cases) 1
• Unexplained clinical deterioration or worsening edema

Key diagnostic criteria:

• Ascitic fluid PMN count >250 cells/mm³ confirms SBP 2, 3
• Send ascitic fluid for cell count, Gram stain, and culture in blood culture bottles 2
• Blood cultures should also be obtained 2

Empirical Antibiotic Selection

The bacteriology in children with nephrotic syndrome differs significantly from cirrhotic adults. Streptococcus pneumoniae accounts for 38% of cases in nephrotic children 1, compared to predominantly gram-negative organisms in cirrhotic adults.

First-line empirical therapy:

• Cefotaxime 50 mg/kg/dose IV every 6-8 hours (maximum 2g/dose) 2, 4
• Alternative: Ceftriaxone 50-75 mg/kg/day IV (maximum 2g/day) 4

This third-generation cephalosporin approach provides:

• Excellent coverage for S. pneumoniae (the dominant pathogen) 1, 5
• Coverage for gram-negative organisms (E. coli, Klebsiella) 2, 4
• High ascitic fluid concentrations 2
• 77-98% infection resolution rates 2

Important caveat: Penicillin-resistant S. pneumoniae has been reported in nephrotic children 6, making third-generation cephalosporins preferable to penicillin monotherapy despite the historical predominance of pneumococcus.

Treatment Duration and Monitoring

• Standard duration: 5-7 days of IV antibiotics 2, 3
• Repeat paracentesis at 48 hours to assess response 3, 7
  • Successful response: PMN count decreases to <25% of baseline 2, 3
  • Treatment failure: PMN count fails to decrease or increases, suggesting resistant organisms or secondary peritonitis 2, 7

If treatment failure occurs:

• Broaden antibiotic coverage based on culture sensitivities 2, 3
• Consider secondary peritonitis (obtain abdominal CT) 4, 7
• Add anaerobic coverage if secondary peritonitis suspected 7

Critical Differences from Adult Cirrhotic SBP

Do NOT routinely use IV albumin in children with nephrotic syndrome and SBP. The albumin protocols (1.5 g/kg day 1 g/kg day 3) are specific to cirrhotic adults with SBP to prevent hepatorenal syndrome 3, 2. This complication mechanism does not apply to nephrotic syndrome, where the pathophysiology involves immunoglobulin deficiency and complement factor deficiencies 5.

Avoid quinolones as first-line therapy in children:

• Quinolone resistance is increasing (up to 31.7% in some regions) 4
• Not appropriate for empirical use in areas with high resistance 2
• Reserved for specific culture-directed therapy

Risk Factors and High-Risk Patients

SBP occurs most commonly in children who are:

• In active relapse (79% of cases) 1
• Receiving steroid therapy 1
• Within first 2 years of nephrotic syndrome diagnosis 8
• Steroid-dependent or steroid-resistant (41% of infections) 5

Notably, 31% of children present with peritonitis as the first manifestation of nephrotic syndrome 5, emphasizing the need for high clinical suspicion.

Prevention Strategies

Pneumococcal vaccination is recommended for all children with nephrotic syndrome 9, 10:

• Give pneumococcal conjugate vaccine (PCV13) and polysaccharide vaccine (PPSV23) per age-appropriate schedules
• Defer live vaccines until prednisone <1 mg/kg/day or <2 mg/kg on alternate days 9
• Annual influenza vaccination for patient and household contacts 9

Antibiotic prophylaxis is NOT routinely recommended for all children with steroid-sensitive nephrotic syndrome 8. Consider prophylaxis only for:

• Children <2 years of age 11
• Steroid-dependent or steroid-resistant disease 8
• Previous episode of pneumococcal infection 11
• Frequently relapsing disease 11

Home monitoring with urine dipsticks for early relapse detection can significantly reduce serious infections by enabling earlier treatment initiation 12.

Common Pitfalls to Avoid

1. Don't wait for culture results - Start empirical antibiotics immediately upon clinical suspicion 2
2. Don't use aminoglycosides - They are nephrotoxic and inappropriate for empirical therapy 2
3. Don't assume negative cultures rule out SBP - 27% of cases are culture-negative but clinically responsive 1
4. Don't extrapolate adult cirrhosis guidelines completely - The microbiology and pathophysiology differ significantly in children with nephrotic syndrome
5. Don't overlook peritonitis as initial presentation - Nearly one-third of children present with infection before nephrotic syndrome diagnosis 5